350 related articles for article (PubMed ID: 26016634)
1. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
Sugita S
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
[TBL] [Abstract][Full Text] [Related]
2. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors.
Sugita S; Iwasaki Y; Makabe K; Kimura T; Futagami T; Suegami S; Takahashi M
Stem Cell Reports; 2016 Oct; 7(4):619-634. PubMed ID: 27641646
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.
Sun J; Mandai M; Kamao H; Hashiguchi T; Shikamura M; Kawamata S; Sugita S; Takahashi M
Stem Cells; 2015 May; 33(5):1543-53. PubMed ID: 25728228
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of T-cell activation by retinal pigment epithelial cells derived from induced pluripotent stem cells.
Sugita S; Kamao H; Iwasaki Y; Okamoto S; Hashiguchi T; Iseki K; Hayashi N; Mandai M; Takahashi M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1051-62. PubMed ID: 25604685
[TBL] [Abstract][Full Text] [Related]
5. Detection of Retinal Pigment Epithelium-Specific Antibody in iPSC-Derived Retinal Pigment Epithelium Transplantation Models.
Sugita S; Makabe K; Fujii S; Iwasaki Y; Kamao H; Shiina T; Ogasawara K; Takahashi M
Stem Cell Reports; 2017 Nov; 9(5):1501-1515. PubMed ID: 29103970
[TBL] [Abstract][Full Text] [Related]
6. Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine.
Matsumoto E; Koide N; Hanzawa H; Kiyama M; Ohta M; Kuwabara J; Takeda S; Takahashi M
PLoS One; 2019; 14(3):e0212369. PubMed ID: 30865653
[TBL] [Abstract][Full Text] [Related]
7. Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling.
Song MJ; Bharti K
Brain Res; 2016 May; 1638(Pt A):2-14. PubMed ID: 26706569
[TBL] [Abstract][Full Text] [Related]
8. Stemming retinal regeneration with pluripotent stem cells.
Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
[TBL] [Abstract][Full Text] [Related]
9. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
Bracha P; Moore NA; Ciulla TA
Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762
[TBL] [Abstract][Full Text] [Related]
11. Natural Killer Cell Inhibition by HLA-E Molecules on Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells.
Sugita S; Makabe K; Iwasaki Y; Fujii S; Takahashi M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1719-1731. PubMed ID: 29610856
[TBL] [Abstract][Full Text] [Related]
12. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
Leach LL; Clegg DO
Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
[TBL] [Abstract][Full Text] [Related]
13. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
Li Y; Chan L; Nguyen HV; Tsang SH
Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
Hazim RA; Karumbayaram S; Jiang M; Dimashkie A; Lopes VS; Li D; Burgess BL; Vijayaraj P; Alva-Ornelas JA; Zack JA; Kohn DB; Gomperts BN; Pyle AD; Lowry WE; Williams DS
Stem Cell Res Ther; 2017 Oct; 8(1):217. PubMed ID: 28969679
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
16. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S
PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843
[TBL] [Abstract][Full Text] [Related]
17. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
O'Neill HC; Limnios IJ; Barnett NL
Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
[TBL] [Abstract][Full Text] [Related]
18. A Strategy for Personalized Treatment of iPS-Retinal Immune Rejections Assessed in Cynomolgus Monkey Models.
Fujii S; Sugita S; Futatsugi Y; Ishida M; Edo A; Makabe K; Kamao H; Iwasaki Y; Sakaguchi H; Hirami Y; Kurimoto Y; Takahashi M
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349277
[TBL] [Abstract][Full Text] [Related]
19. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells.
Buchholz DE; Hikita ST; Rowland TJ; Friedrich AM; Hinman CR; Johnson LV; Clegg DO
Stem Cells; 2009 Oct; 27(10):2427-34. PubMed ID: 19658190
[TBL] [Abstract][Full Text] [Related]
20. Induction of retinal pigment epithelial cells from monkey iPS cells.
Okamoto S; Takahashi M
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8785-90. PubMed ID: 21896853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
